These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 18585530)

  • 1. Lyssaviruses: current trends.
    Nadin-Davis SA; Fehlner-Gardiner C
    Adv Virus Res; 2008; 71():207-50. PubMed ID: 18585530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research Advances on the Interactions between Rabies Virus Structural Proteins and Host Target Cells: Accrued Knowledge from the Application of Reverse Genetics Systems.
    Yin J; Wang X; Mao R; Zhang Z; Gao X; Luo Y; Sun Y; Yin X
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Codon optimization of G protein enhances rabies virus-induced humoral immunity.
    Pei J; Huang F; Wu Q; Luo Z; Zhang Y; Ruan J; Li Y; Zhou M; Fu Z; Zhao L
    J Gen Virol; 2019 Aug; 100(8):1222-1233. PubMed ID: 31259681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A recombinant rabies virus encoding two copies of the glycoprotein gene confers protection in dogs against a virulent challenge.
    Liu X; Yang Y; Sun Z; Chen J; Ai J; Dun C; Fu ZF; Niu X; Guo X
    PLoS One; 2014; 9(2):e87105. PubMed ID: 24498294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICAM-1-based rabies virus vaccine shows increased infection and activation of primary murine B cells in vitro and enhanced antibody titers in-vivo.
    Norton JE; Lytle AG; Shen S; Tzvetkov EP; Dorfmeier CL; McGettigan JP
    PLoS One; 2014; 9(1):e87098. PubMed ID: 24489846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic engineering of live rabies vaccines.
    Morimoto K; McGettigan JP; Foley HD; Hooper DC; Dietzschold B; Schnell MJ
    Vaccine; 2001 May; 19(25-26):3543-51. PubMed ID: 11348722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2.
    Patial S; Chaturvedi VK; Rai A; Saini M; Chandra R; Saini Y; Gupta PK
    Vaccine; 2007 May; 25(20):4020-8. PubMed ID: 17391817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-based immunisation against rabies and rabies-related viruses: towards multivalent vaccines.
    Perrin P; Jacob Y; Desmézières E; Tordo N
    Dev Biol (Basel); 2000; 104():151-7. PubMed ID: 11713814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
    Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
    Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of ORFV-based vectors expressing the rabies virus glycoprotein in livestock species.
    Martins M; Joshi LR; Rodrigues FS; Anziliero D; Frandoloso R; Kutish GF; Rock DL; Weiblen R; Flores EF; Diel DG
    Virology; 2017 Nov; 511():229-239. PubMed ID: 28898730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of P gene-deficient rabies virus.
    Shoji Y; Inoue S; Nakamichi K; Kurane I; Sakai T; Morimoto K
    Virology; 2004 Jan; 318(1):295-305. PubMed ID: 14972555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-Inducible GTPase 1 Impedes the Dimerization of Rabies Virus Phosphoprotein and Restricts Viral Replication.
    Tian B; Yuan Y; Yang Y; Luo Z; Sui B; Zhou M; Fu ZF; Zhao L
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rabies vaccine].
    Morimoto K; Takayama-Ito M
    Nihon Rinsho; 2005 May; 63 Suppl 5():654-8. PubMed ID: 15954425
    [No Abstract]   [Full Text] [Related]  

  • 14. Pre- and post-exposure safety and efficacy of attenuated rabies virus vaccines are enhanced by their expression of IFNγ.
    Barkhouse DA; Faber M; Hooper DC
    Virology; 2015 Jan; 474():174-80. PubMed ID: 25463615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AAV-expressed G protein induces robust humoral and cellular immune response and provides durable protection from rabies virus challenges in mice.
    Liu C; Li J; Yao Q; Gao Z; Cheng Y; Zhou M; Tang Y; Sun L; Dai J; Cao G; Zhang XL; Zhang R
    Vet Microbiol; 2020 Mar; 242():108578. PubMed ID: 32122589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune efficacy of rabies virus glycoprotein expressed by baculovirus vector].
    Chen Q; Zhang SF; Liu Y; Fu YH; Sun CL; Yang Y; Gong T; Song FF; Hu RL
    Bing Du Xue Bao; 2012 Sep; 28(5):501-5. PubMed ID: 23233923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of non-human primates against rabies with an adenovirus recombinant vaccine.
    Xiang ZQ; Greenberg L; Ertl HC; Rupprecht CE
    Virology; 2014 Feb; 450-451():243-9. PubMed ID: 24503087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a recombinant rabies Flury LEP virus carrying an additional G gene creates an improved seed virus for inactivated vaccine production.
    Tao L; Ge J; Wang X; Wen Z; Zhai H; Hua T; Zhao B; Kong D; Yang C; Bu Z
    Virol J; 2011 Sep; 8():454. PubMed ID: 21943337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of neurovirulence of flury rabies virus vaccine strains: importance of the polymerase and the glycoprotein R333Q mutation.
    Tao L; Ge J; Wang X; Zhai H; Hua T; Zhao B; Kong D; Yang C; Chen H; Bu Z
    J Virol; 2010 Sep; 84(17):8926-36. PubMed ID: 20538851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chimpanzee-origin adenovirus vector expressing the rabies virus glycoprotein as an oral vaccine against inhalation infection with rabies virus.
    Zhou D; Cun A; Li Y; Xiang Z; Ertl HC
    Mol Ther; 2006 Nov; 14(5):662-72. PubMed ID: 16797238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.